PALO ALTO, CALIFORNIA / ACCESS Newswire / January 27, 2025 / Bioz, Inc., a pioneer in AI-driven tools for scientific discovery, is transforming the way scientists discover and evaluate scientific ...

Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly subcutaneous administration.

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

Original-Research: Cantourage Group SE - from NuWays AG27.01.2025 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The issuer is solely responsible for the ...

In-Depth Technical Insights Supporting the Enhanced KPIs for Trusted Results TAMPA, FLORIDA / ACCESS Newswire / January 26, 2025 / Black Book™ has developed eighteen enhanced Key Performance ...

TAMPA, FLORIDA / ACCESS Newswire / January 25, 2025 / Black Book Market Research LLC announces the release of the 2025 Black Book of Healthcare Cybersecurity, an extensive and meticulously curated LLM ...

CEO and biomedical engineer George K. Lewis will discuss the clinical effectiveness of sustained acoustic medicine in ...

CLASS data FOR NOVEL APPROACH TO CANCER treatmentParsortix system used to identify patients with highly metastatic CTC clusters for targeted treatmentNew treatment strategy provides 'uncharted ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...

Preliminary ResultsPentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million24-Jan-2025 / 17:00 ...

In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services. VTT Technical Research Centre of Finland, ...